Phio Pharmaceuticals (PHIO) Current Deferred Revenue (2011 - 2014)
Phio Pharmaceuticals' Current Deferred Revenue came in at $47,000 for Q4 2014, down 60.2% from $118,000 a year earlier and down 23.0% from the prior quarter.
Powered by 
Analysis
Phio Pharmaceuticals (PHIO) Current Deferred Revenue (2011 - 2014) Analysis & Trends
Going back to Q4 2011, Phio Pharmaceuticals' Current Deferred Revenue data covers 13 quarters.
- Current Deferred Revenue has declined in each of the last three years, with a three-year compound annual growth rate of -61.4% (FY2011 to FY2014).
- Going back by year, Current Deferred Revenue was $118,000 in FY2013 (-76.0%), $491,000 in FY2012 (-39.8%) and $816,000 in FY2011.
- The Q4 2014 figure represents the lowest quarterly Current Deferred Revenue in data going back to Q4 2011.
- Year-over-year, Current Deferred Revenue has declined for nine consecutive quarters, with an average decline of 61.7% over the last eight quarters.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 39.8% (Q4 2012) to 80.8% (Q1 2014).
- Business Quant data shows PHIO's Current Deferred Revenue at $61,000 (Q3 2014), $78,000 (Q2 2014) and $89,000 (Q1 2014) in the three quarters before Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Phio Pharmaceuticals | 10.57 Mn | -51.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | 47,000.00 |
| Sep 30, 2014 | 61,000.00 |
| Jun 30, 2014 | 78,000.00 |
| Mar 31, 2014 | 89,000.00 |
| Dec 31, 2013 | 118,000.00 |
| Sep 30, 2013 | 147,000.00 |
| Jun 30, 2013 | 239,000.00 |
| Mar 31, 2013 | 464,000.00 |
| Dec 31, 2012 | 491,000.00 |
| Sep 30, 2012 | 370,000.00 |
| Jun 30, 2012 | 468,000.00 |
| Mar 31, 2012 | 797,000.00 |
| Dec 31, 2011 | 816,000.00 |
API Access
Phio Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PHIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "PHIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PHIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();